Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Aes-103 5-hydroxymethyl-2-furfural: Phase II start

This month, AesRx will begin a double-blind, placebo-controlled Phase II trial to evaluate Aes-103 for 28

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE